The realistic timeline Based on the current state of the clinical program, regulatory precedent, and publicly available information from Eli Lilly, here is the most realistic projection: Mid to late 2026: Remaining TRIUMPH, TRANSCEND, and SYNERGY Phase 3 results are reported
Most AEs were mild and GI-related, consistent with GLP-1RAs
The Food and Drug Administration and healthcare professionals warn of these common signs of a counterfeit product : No Prescription Required: Legitimate weight loss programs always require a medical consultation to review your medical condition and health conditions
The cost of these medications [to insurers], often ranging from $950 to $1,400 per month, has proven unsustainable and contributes significantly to rising premiums for individuals, employers, and the Commonwealth, said Lora Pellegrini, president of the Massachusetts Association of Health Plans, which represents Point32Health and about a dozen other insurers